Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Arc-1 vs Boston Medical Group

Arc-1
Graded #417

Lower grade

vs+13.600000000000009
Boston Medical Group
Graded #113

Higher grade

The verdict

Boston Medical Group takes it — 69.9/100 to 56.3/100.

Boston Medical Group grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Established medical group offering a 3-month semaglutide weight loss program.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBoston Medical Group +42
44
86
Dose & formulationArc-1 +2
54
52
Clinical oversightBoston Medical Group +17
72
89
Labs & monitoringBoston Medical Group +1
52
53
FulfillmentBoston Medical Group +3
62
65
Contract termsArc-1 +6
61
55
Arc-1 · left barBoston Medical Group · right bar

The numbers

MetricArc-1Boston Medical Group
WeighScore56.3/10069.9/100
GradeCC
Scorecard rank#417#113
Semaglutide$200/mo (0.5 mg dose, compounded)$66/mo (starting dose, compounded)
Tirzepatide$200/mo (2.5 mg dose, compounded)Not disclosed
CoverageCoverage not published7 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Arc-1

Graded #417 · C

Strengths

  • Both compounded semaglutide and tirzepatide available
  • Per-dose purchasing — no subscription or membership required
  • 25% off plus free shipping promotion
  • Broader longevity formulary (rapamycin, NAD+, sermorelin)
  • LegitScript Certified badge now displayed on product pages

Where it loses points

  • No legal entity name or address disclosed
  • State availability not disclosed
  • No named clinicians or pharmacy partners
  • Per-dose pricing still climbs with dose (semaglutide 2.5mg is $549.99/mo, tirzepatide 7.5mg $399.99/mo)
Boston Medical Group

Graded #113 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard